Form 483

CTK OTC Laboratories LLC Form 483, 2024-12-31

FDA issued a Form 483 to CTK OTC Laboratories LLC on 2024-12-31 with 4 public-safe observations.

483· Form 483 issuedHuman Drugs4 observations

CTK OTC Laboratories LLC · Corona, United States · Issued December 31, 2024

Overview

  • 4 public-safe observations are available for this inspection.
  • 4 structured CFR citations are represented.
  • 1 investigator is tied to this Form 483.

Inspectional observations

Each observation cites the regulation FDA found the firm out of compliance with.

31 Dec 2024
21 CFR 211.110(a)

Written in-process control procedures

Cited by Pearl C Ozuruigbo

31 Dec 2024
21 CFR 211.192

No written record of investigation

Cited by Pearl C Ozuruigbo

31 Dec 2024
21 CFR 211.194(a)(2)

Suitability of testing methods verified

Cited by Pearl C Ozuruigbo

31 Dec 2024
21 CFR 211.63

Equipment Design, Size and Location

Cited by Pearl C Ozuruigbo

Inspected site

COCTK OTC Laboratories LLCCorona, United States

Inspection team

Cited regulations

CFR citations associated with this Form 483.

CitationWhat it coversCited
21 CFR 211.110(a)Cited across public-safe Form 483 observations1x
21 CFR 211.192Cited across public-safe Form 483 observations1x
21 CFR 211.194(a)(2)Cited across public-safe Form 483 observations1x
21 CFR 211.63Cited across public-safe Form 483 observations1x

Source document

PDF
PDF available

Form 483 source document

The source document is available to authorized Atlas users.

Full 483 report

Get the verbatim text of all 4 observations

The source PDF, so your team sees exactly what was cited and how it was answered.

  • The site's full inspection history around this Form 483
  • Whether these citations escalated to a warning letter
  • The investigators involved and the citations they repeat elsewhere